These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10372689)

  • 1. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women.
    Hadigan C; Miller K; Corcoran C; Anderson E; Basgoz N; Grinspoon S
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1932-7. PubMed ID: 10372689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperandrogenemia in human immunodeficiency virus-infected women with the lipodystrophy syndrome.
    Hadigan C; Corcoran C; Piecuch S; Rodriguez W; Grinspoon S
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3544-50. PubMed ID: 11061499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of polycystic ovary syndrome features in human immunodeficiency virus-infected women despite significant hyperinsulinemia and truncal adiposity.
    Johnsen S; Dolan SE; Fitch KV; Killilea KM; Shifren JL; Grinspoon SK
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5596-604. PubMed ID: 16076939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy.
    Yanovski JA; Miller KD; Kino T; Friedman TC; Chrousos GP; Tsigos C; Falloon J
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1925-31. PubMed ID: 10372688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy.
    Rietschel P; Hadigan C; Corcoran C; Stanley T; Neubauer G; Gertner J; Grinspoon S
    J Clin Endocrinol Metab; 2001 Feb; 86(2):504-10. PubMed ID: 11158000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Miller K; Biller BM; Askari H; Wang E; Hubbard J; Anderson EJ; Basgoz N; Heller HM; Klibanski A
    J Clin Endocrinol Metab; 1997 May; 82(5):1332-7. PubMed ID: 9141512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices.
    Tong Q; Sankalé JL; Hadigan CM; Tan G; Rosenberg ES; Kanki PJ; Grinspoon SK; Hotamisligil GS
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1559-64. PubMed ID: 12679439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution.
    Torriani M; Thomas BJ; Barlow RB; Librizzi J; Dolan S; Grinspoon S
    J Appl Physiol (1985); 2006 Feb; 100(2):609-14. PubMed ID: 16223978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperinsulinemia in nonobese women reporting a moderate weight gain at the beginning of menopause: a useful early measure of susceptibility to insulin resistance.
    Lemay A; Turcot L; Déchêne F; Dodin S; Forest JC
    Menopause; 2010 Mar; 17(2):321-5. PubMed ID: 19745772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution.
    Meininger G; Hadigan C; Laposata M; Brown J; Rabe J; Louca J; Aliabadi N; Grinspoon S
    Metabolism; 2002 Feb; 51(2):260-6. PubMed ID: 11833059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome.
    Torriani M; Hadigan C; Jensen ME; Grinspoon S
    J Appl Physiol (1985); 2003 Sep; 95(3):1005-10. PubMed ID: 12766180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic abnormalities in HIV type 1-infected children treated and not treated with protease inhibitors.
    Melvin AJ; Lennon S; Mohan KM; Purnell JQ
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1117-23. PubMed ID: 11522181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
    Bhasin S; Parker RA; Sattler F; Haubrich R; Alston B; Umbleja T; Shikuma CM;
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1049-57. PubMed ID: 17164307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study.
    Saint-Marc T; Partisani M; Poizot-Martin I; Rouviere O; Bruno F; Avellaneda R; Lang JM; Gastaut JA; Touraine JL
    AIDS; 2000 Jan; 14(1):37-49. PubMed ID: 10714566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance.
    Hadigan C; Meigs JB; Rabe J; D'Agostino RB; Wilson PW; Lipinska I; Tofler GH; Grinspoon SS;
    J Clin Endocrinol Metab; 2001 Feb; 86(2):939-43. PubMed ID: 11158071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.
    Hadigan C; Meigs JB; Corcoran C; Rietschel P; Piecuch S; Basgoz N; Davis B; Sax P; Stanley T; Wilson PW; D'Agostino RB; Grinspoon S
    Clin Infect Dis; 2001 Jan; 32(1):130-9. PubMed ID: 11118392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy.
    Luzi L; Perseghin G; Tambussi G; Meneghini E; Scifo P; Pagliato E; Del Maschio A; Testolin G; Lazzarin A
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E274-80. PubMed ID: 12388139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin sensitivity and beta-cell function in protease inhibitor-treated and -naive human immunodeficiency virus-infected children.
    Bitnun A; Sochett E; Dick PT; To T; Jefferies C; Babyn P; Forbes J; Read S; King SM
    J Clin Endocrinol Metab; 2005 Jan; 90(1):168-74. PubMed ID: 15483082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy.
    Gan SK; Samaras K; Thompson CH; Kraegen EW; Carr A; Cooper DA; Chisholm DJ
    Diabetes; 2002 Nov; 51(11):3163-9. PubMed ID: 12401706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.